Hikma last year acquired the US generic drugs business of Boehringer Ingelheim and has now sealed another acquisition. AP
Hikma last year acquired the US generic drugs business of Boehringer Ingelheim and has now sealed another acquisition. AP

Hikma Pharmaceuticals buys US-based Custopharm to boost injectables business